Table 4. Association between COL6A4P2 polymorphism and tumor staging of lung cancer.
SNP ID | Model | Genotype | Control | Case | OR (95%CI) | p |
---|---|---|---|---|---|---|
rs77941834 | Codominant | TT | 57 | 210 | 1.00 | |
TA | 23 | 46 | 0.52 (0.29–0.94) | 0.030 | ||
AA | 4 | 5 | 0.33 (0.09–1.31) | 0.116 | ||
Dominant | TT | 57 | 210 | 1.00 | ||
TA/AA | 27 | 51 | 0.49 (0.28–0.86) | 0.013 | ||
Recessive | TT/TA | 80 | 256 | 1.00 | ||
AA | 4 | 5 | 0.39 (0.10–1.49) | 0.167 | ||
Log-additive | 0.55 (0.34–0.87) | 0.011 |
SNP = single nucleotide polymorphism; OR = odds ratio; 95%CI = 95% confidence interval.
p < 0.05 indicates statistical significance.
Bold values indicate a significant difference.